Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 27, 2016OncotargetOpen Access

IL-1 drives breast cancer growth and bone metastasisin vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

IHIngunn HolenUniversity of SheffieldDLDiane V. LefleyUniversity of SheffieldSFSheila FrancisInsigneo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Holen et al. (2016) studied this question.

synapsesocial.com/papers/6a6f358cce524a4339c338aahttps://doi.org/10.18632/oncotarget.12289
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer2015 · 54 citations
  2. 2Molecular Link Mechanisms between Inflammation and Cancer2012 · 417 citations
  3. 3Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment2006 · 460 citations
  4. 4Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth<i>In vivo</i>2008 · 90 citations
  5. 5Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β22014 · 64 citations